Results 211 to 220 of about 74,972 (273)

Estrogen receptor-positive, BRCA1-deficient breast cancer: BRCA1-epimutated tumors presenting a piece to the puzzle. [PDF]

Breast Cancer Res
Lønning PE, Nikolaienko O, Knappskog S.
europepmc   +1 more source

Rare <i>BRCA1</i> c.3418_3419insTGACTACT:p.S1140Mfs*18 germline mutation in a family with breast and ovarian cancer. [PDF]

Oncol Lett
Zhai C, Jia L, Wang C, Chen L, Han T, Xiao D.   +5 more
europepmc   +1 more source

Factors influencing uptake of risk-reducing mastectomy among unaffected Israeli BRCA1/BRCA2 pathogenic variant carriers. [PDF]

Fam Cancer
Laitman Y, Aharon K, Schloss T, Margolin L, Friedman E.   +4 more
europepmc   +1 more source

SERBP1 is required for efficient HR repair and cisplatin chemoresistance in lung adenocarcinoma. [PDF]

Cell Death Discov
Xie Y, Chen Q, Tang N, Zeng Y, Zhao J, Yang Y, Li C, Li J, Zhu J, Huang JA, Liu Z.   +10 more
europepmc   +1 more source

Breast cancer risk genes affecting individual radiosensitivity. [PDF]

Sci Rep
Vogel RKG, Amann N, Kassem TZ, Gaß P, Mayo T, Woltereck F, Hack CC, Fietkau R, Corradini S, Distel L, Kuhlmann LCF.   +10 more
europepmc   +1 more source

Enhanced Detection of BRCA Copy Number Alterations Within a Commercial HRD Assay: Implications for Precision Oncology in Ovarian Cancer. [PDF]

Int J Mol Sci
De Bonis M, Iapicca P, De Paolis E, Brisighelli F, Evangelista J, Perrucci A, Ricciardi Tenore C, Maneri G, Concolino P, Piermattei A, Mozzetta I, Pasciuto T, Preziosi A, Giacò L, Duranti S, Nero C, Fagotti A, Minucci A.   +17 more
europepmc   +1 more source

Loss of CHTF18-RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors. [PDF]

NAR Cancer
Buckley-Benbow L, Ozgencil M, Tardocchi A, Agnarelli A, Bellelli R.   +4 more
europepmc   +1 more source

Single-cell RNA sequencing reveals immune microenvironment heterogeneity in BRCA1-mutated and sporadic triple-negative breast cancer. [PDF]

Transl Oncol
Sun Q, Zhong Y, Sun C.
europepmc   +1 more source

BRCA1/2 Reversion Mutations in Japanese Patients with Metastatic Breast Cancer Progressing on Olaparib: OLIVE (WJOG15321B). [PDF]

Breast Cancer
Sakai H, Kusumoto-Matsuo R, Hosonaga M, Nozawa K, Futamura M, Tanabe Y, Mukohara T, Shiraishi K, Toyama T, Yasojima H, Watanabe N, Sakai H, Iwasa T, Takeuchi N, Tada H, Sakai K, Chiba N, Takano T, Tsurutani J.   +18 more
europepmc   +1 more source